In terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, GlaxoSmithKline Pharmaceuticals has informed that the trading period for buying or selling of Company's shares is closed from Thursday, 1st January 2026 till 48 hours after the announcement/declaration of the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2025. The date of Board Meeting for declaration of the Unaudited Financial Results of the Company for the quarter & nine months ended 31st December 2025 will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
